chrisvoncsefalvay/vaers-outcomes huggingface dataset:
losing a little bit of weight; he received 2 doses of the Pfizer Covid-19 vaccine as well as 1 booster dose of the Pfizer Covid-19 vaccine. Caller provided that he is still testing positive for Covid; he received 2 doses of the Pfizer Covid-19 vaccine as well as 1 booster dose of the Pfizer Covid-19 vaccine. Caller provided that he is still testing positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure medication" (unspecified if ongoing). Concomitant medication(s) included: FISH OIL; D3 VITAMIN; FOLIC ACID; METFORMIN; LOSARTAN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "not recovered" and all described as "he received 2 doses of the Pfizer Covid-19 vaccine as well as 1 booster dose of the Pfizer Covid-19 vaccine. Caller provided that he is still testing positive for Covid"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "losing a little bit of weight". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive, notes: testing positive for Covid 10 days ago; Weight: (unspecified date) losing a little bit of weight, notes: Caller provided that he is "losing a little bit of weight".  Clinical course: Caller was prescribed Paxlovid, after testing positive for Covid 10 days ago. Caller stated that he received 2 doses of the Pfizer Covid-19 vaccine as well as 1 booster dose of the Pfizer Covid-19 vaccine. He still tested positive for Covid, but did not have symptoms real bad." He still had his taste and smell, had an appetite, and had been eating normal for more than a week. Was losing a little bit of weight and did not have much fever. He remained isolated since he has tested positive. He was advised to take cholesterol medication but he had stopped taking, however he was also taking fish oil, D3 vitamin, folic acid, high blood pressure medication, metformin, and losartan. Caller is worried about taking Paxlovid and was not sure if he should take it. Caller read that the product was under EUA and stated that he did not feel he needed it in an emergency. Caller provided that his daughter had covid for 5 days then tested negative and his wife was testing negative as well. Caller agreed to contact his HCP to discuss his concerns. He was asking if he had to take Paxlovid.  Follow-up attempts are completed. No further information is expected.
Severe full body muscle aches resulting in loss of work; severe full body muscle aches resulting in loss of work and difficulty getting out of bed; Continued period, and approximately 1 week after the shot; Heavy bleeding; Very heavy bleeding and severe cramps; Nausea; Fatigue; Severe arm soreness at shot location; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in right arm on 20Apr2021 at 15:15 hours (at the age of 22-year-old) as single dose for COVID-19 immunisation. The medical history of the patient included blood clots (continued use of blood thinners), depression and a birth control user at the time of this report. The patient received rivaroxaban (XARELTO) 10 mg, norethisterone (NORETHINDRONE), citalopram (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) on an unknown date within 2 weeks prior to the COVID-19 vaccine for an unknown indication. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in left arm on 30Mar2021 at 15:15 hours as single dose for COVID immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. Post the vaccination, the patient was not tested for COVID-19. On 21Apr2021, on the day following the vaccine shot, the patient experienced severe arm soreness at shot location, nausea, fatigue, and severe full body muscle aches resulting in loss of work and difficulty getting out of bed. Pain was still serious after taking acetaminophen but was eased after taking Percocet. The patient was on period at the time of the COVID vaccine and it should have ended a few days after receiving it. However, it continued for approximately one week after the shot, it intensified to several days of very heavy bleeding and severe cramps. For comparison, she did not have cramps that bad since beginning birth control three years ago, and the cramps usually never last longer than 24 hours. The flow was also greatly increased, around twice as heavy as her usual heavy days. These increased cramps and bleeding lasted around four days. Therapeutic measures were taken as a result of the events and included treatment with acetaminophen and Percocet. The clinical outcome for the events severe arm soreness at shot location, nausea, fatigue, severe full body muscle aches resulting in loss of work and difficulty getting out of bed was recovering and for the events of continued period, for approximately one week after the shot, heavy bleeding and severe cramps was recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot number cannot be obtained.
No adverse effects; A 2 month-old patient was given a dose of VAQTA/The healtcare worker believed it was time for the patient to receive VAQTA, when it was actually time for the patient to be administered with hepatitis B vaccine; The VAQTA was administered instead of a Hepatitis B vaccine; This spontaneous report was received from a nurse, concerning a 2-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and past drug allergies or reactions were not reported.    On 21-AUG-2019, the patient was vaccinated with a dose (one dosage form) of hepatitis a vaccine, inactivated (VAQTA) 25/0.5, intramuscularly for prophylaxis (anatomical site of injection was not reported), lot number R034340 with expiration date on 23-NOV-2019, instead of hepatitis B vaccine (wrong product administered/ product administered to patient of inappropriate age) that was confirmed it was not Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB).  On 07-NOV-2019, the patient received the correspondence dose of hepatitis B vaccine (strength, route of administration, and anatomical site of injection were not reported), lot number KC57F with expiration date on 04-SEP-2021.   The reporter also stated that it was not product confusion as the healthcare worker who administered the vaccine had believed it was time for the patient to be administered hepatitis a vaccine, inactivated (VAQTA). No adverse effects reported nor product quality complain involved.
PATIENT STATED HE HAD SIGNS OF FLU-LIKE SYMPTOMS, FATIGUE, FEVER, PAIN, SORENESS, N/V, REDNESS AND CONSTIPATION. HE STATES HE HAD SEVERE BACK PAIN AND HAD TO STAY THE DAY IN BED RESTING.
pt recv vax;exp breakthrough chicken pox w/ 120 lesions throughout body;had fever,v,coughing,itching and pharyngitis;
Pt devel muscle weakness following vax w/Hep B; No further details were provided;
5d after vaccine I developed a R sided trigeminal neuralgia of branches 1 & 2.  By d10 I developed the rash consistent with herpes zoster, including ophthalmic involvement of the R eye.  I have not previously had shingles, but did have varicella as a child.  I went to the ER as it was the middle of the night on the weekend and as a physician I realized the eye involvement required immediate treatment.  I have since had to see the ophthalmologist x2.  The shingles itself is improving, and the eye has healed with steroids and valtrex.  I did still receive my 2nd booster shot on 1/5/21 and thus far have not had any additional effects.
Chills, feverish, lower abdominal pain, headache and lower back pain symptoms.
Chills; Fever; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left shoulder on 18Mar2021 (at the age of 65-year-old) as dose 2, single for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing History and Investigations: Not taking any other medications than high blood pressure. Patient concomitant medications were not specified. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EN5318), via an unspecified route of administration, administered in left shoulder on 25Feb2021 (at the age of 65-year-old) as dose 1, single for covid-19 immunisation. Patient had a Flu shot and started feeling feverish. Last winter did not feel feverish. Did feel feverish after Flu shot in 2019. On 18Mar2021, the patient experienced chills. On an unspecified date in Mar2021, patient experienced. Had chills through the night of 18Mar2021. Probably was running a fever then. Patient Hadn't taken aspirin or Advil or anything like that. The patient underwent lab tests and procedures which included body temperature: 100.7 on Mar2021 fairly steady bouncing between 00 degrees and 101 degrees, body temperature: 101 on 19Mar2021 degree. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient received a dose of V ARlV AX on 2/25/2011 that expired in; no other adverse event; This spontaneous report was received from a registered nurse, concerning a female patient of unknown age. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided.   On 25-FEB-2021, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis, lot number reported as 1699Z with an expiration date reported as 1991 (strength and route of administration were not reported). The vaccine was administered at another facility and no additional information was obtained, however, the patient thought the expiration date was entered into the system incorrectly, but they did not have documentation to confirm this. No other adverse event was reported.
Patient was administered 0.5ml instead of 0.25ml, patient was called on1/19/2022 and denies any problems since vaccination. Letter was sent to patient informing of dosage given
BRUE QUIT BREATHING STARTED AT ER WAS ADITTED AT HOSPITAL FOR 2 DAYS
On the way home from our office child began with a rash cough rubbing skin (child is non-verbal) parent brought child to ER. Dx anaphylaxis. Child also had allergy scratch test in am.
Pt reports hives on face that occurred 4 days post vaccines (TDAP, MENVEO, HPV) pt also with intermittent  lip swelling, vomiting and itching throat.
"Moderna Covid-19 Vaccine EUA" - On 1/25 evening my arm pit area in the arm I received the injection is began to feel tender and a little painful. Late that night my injection site started to become red, swollen, hard, hot to the touch, and itchy. As of 1/29, arm pit area is less tender and not painful, and injection site reaction is improving (swelling as gone down, still a little red but noticeably better).
11-26-02 had flu-like symptoms and pain in left arm; 11-27-02 arm became swollen and red, hot touch from injection site down below elbow.
This spontaneous report as received from a pharmacist via a company representative refers to a 66 year old female patient. Medical history and drug allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (concentration, dose, frequency and lot number were not reported). No concomitant therapy was reported. On an unknown date, the patient experienced unusually large injection site rashes 10 days after receiving ZOSTAVAX. The rash was extremely swollen, hot and red. The patient did not sought medical attention. The outcome of the event was unknown. This is one of several reports from the same source. Additional information has been requested.
lack of appetite; lack of energy; diarrhea; Aches/ pains; nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains) and NAUSEA (nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (lack of appetite), ASTHENIA (lack of energy), DIARRHOEA (diarrhea), MYALGIA (Aches/ pains), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  Patient quit smoking 14 years ago.   This case was linked to MOD-2021-341298 (Patient Link).
Full body rash; started off spotty the day after my vaccination. When I woke up the following morning, it was a full body rash that appeared like a sunburn. It was itchy, tight, and burning. I was seen at the Urgent Care Sunday 1/29/2022 and was prescribed methylprednisolone for 6 days.
Fatigue; Fever; Mild joint achiness; Neck muscles sore; Pressure in head; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 24Mar2021 at 16:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had food, grass and sesame seeds allergy. Concomitant medications included hydrochlorothiazide, valsartan (VALSARTAN HCTZ), amlodipine (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the arm left on 03Mar2021 at 16:45 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 08:00 the patient experienced fatigue, fever, mild joint achiness, neck muscles sore and pressure in head. No therapeutic measures were taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fatigue, fever, mild joint achiness, neck muscles sore and pressure in head was recovered on an unspecified date.    No follow-up attempts are needed. No further information is expected.
still wakes up, it was in my eye; 3 times 1st time was hell it took over 2vyrs heal up it still wakes up in me; painful and aggravating I couldn't wear clothing/still have pins, needles pain; I couldn't wear clothing for a year; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), shingles, pain and activities of daily living impaired. On an unknown date, the outcome of the ophthalmic herpes zoster and shingles were unknown and the outcome of the pain was not recovered/not resolved and the outcome of the activities of daily living impaired was recovered/resolved.   It was unknown if the reporter considered the ophthalmic herpes zoster, shingles, pain and activities of daily living impaired to be related to Shingles vaccine.     Additional Information: GSK receipt date: 28-FEB-2023 Reporter Comment: This case was reported by a patient via interactive digital media. The reporter reported that, he/ she got 3 times 1st time was hell it took over 2 years heal up it (shingles) still wakes up in her/him last time 5 months ago from reporting it was in his/her eye. The patient got 1st part vaccine it almost killed her/him. The doctor said not to get the 2nd part. The patient pray he/she got enough vaccine to fight it off the rest his/her life remainder.  The patient stated that good luck to all it was painful and aggravating. The patient could not wear clothing for a year and he /she still had pins needles pain comes and goes. Additional Supportive Information: As it was not clear if the event Shingles and ophthalmic herpes zoster were experienced before or after vaccination hence conservatively captured as event. The follow-up could not be possible as no contact details were available.
Left arm very sore, radiating pain down to breasts, painful joints, headache, coughing,  insomnia.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On 29-JAN-2013 the patient was vaccinated with a dose of expired live, oral ROTATEQ (lot # 670243/0921AA, expiration date 15-DEC-2012) orally. It was not known which dose in the live, oral ROTATEQ vaccination series this dose was administered. No adverse effect reported. This is one of the several reports from the same source. Additional information has been requested.
0.1 mL intradermally for two Jynneos doses six doses administered to three patients; Case reference number US-BN-2023-001330 is a spontaneous case report initially received on 01-Aug-2023 from a nurse via agency (reference number: USBAV23-1106) and concerns *three* patients of unknown demographics.  The patients' relevant medical history and concomitant medications were not reported.  *On unspecified dates, three patients received two doses of Jynneos (batch number: unknown), at a dose of 0.1 ml, intradermally (ID), at unknown site of administration for smallpox/monkeypox prophylaxis (explicitly coded as 'intradermal injection').  As reported, six doses of Jynneos vaccine were administered.*  *At the time of this follow up report, it was unknown if three patients experienced any adverse event due to Jynneos vaccination.*  Additional information received from Bavarian Nordic on 02-Aug-2023 included local BN case ID.  All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*).  Follow-up information received from nurse on 16-Aug-2023. New information included number of patients and confirmation that administered Jynneos vaccines to patients were before the previously reported Jynneos temperature excursion and that no patient was given affected Jynneos during the unstable period, so the special situations of '14 doses of Jynneos had excursion every time a new pharmacist come in, Jynneos been administered six times' (explicitly coded as 'product storage error temperature too high' and 'product administration error') were removed.; Reporter's Comments: Three patients of unknown demographics received two doses of Jynneos, 0.1 mL applied intradermally (which is considered intradermal injection), for smallpox/mpox prophylaxis. No associated adverse events or issues were reported. Intradermal injection is considered listed per company convention. Medical history and concomitant medications were unavailable. Intradermal injection is not related to Jynneos, but to human factor. The case is non-serious.; Sender's Comments: Three patients of unknown demographics received two doses of Jynneos, 0.1 mL applied intradermally (which is considered intradermal injection), for smallpox/mpox prophylaxis. No associated adverse events or issues were reported. Intradermal injection is considered listed per company convention. Medical history and concomitant medications were unavailable. Intradermal injection is not related to Jynneos, but to human factor. The case is non-serious.
5 minutes after COVID vaccine injection administered, patient voiced trouble breathing to provider while in room. Began checking BP, HR, & O2 per provider guidance. After 15 minutes patient shows/voices no signs of abnormal/Adverse reaction.
Patient states that on the first vaccine she experienced a bad headache which is a common side effect. She states it was the second dose that caused her to have issues with dizziness within an hour after having the second dose. She states the dizziness isn't positional and has been on and off she since had the second dose back in April. She also still has reoccurring headaches and isn't sure if these are contributed to it but the most concern is the dizziness as she states she has a few times where she has had to pull over while driving because of it.
fine, bumps all over body-itching from head to toe-rx w/DPH cream-overnight-sx cont-pt thinks has hives;
Pain, / in the arm (site of injection); swollen / in the arm (site of injection); redness in the arm (site of injection); general discomfort.; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced injection site pain, injection site swelling, injection site erythema and general discomfort. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema and general discomfort were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema and general discomfort to be related to Bexsero.  Additional details were reported as follows: The age at vaccination was not reported. Nurse informed that after the vaccination of patient with Bexsero, the patient experienced pain, swollen, redness in the arm (site of injection) and general discomfort. The reporter consented to follow up. This case is 1 of the 13 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR209822:same reporter US-GLAXOSMITHKLINE-US2020AMR210157:same reporter US-GLAXOSMITHKLINE-US2020208660:same reporter US-GLAXOSMITHKLINE-US2020AMR210158:same reporter US-GLAXOSMITHKLINE-US2020AMR210159:same reporter US-GLAXOSMITHKLINE-US2020AMR210161:same reporter US-GLAXOSMITHKLINE-US2020AMR210162:same reporter US-GLAXOSMITHKLINE-US2020AMR210163:same reporter US-GLAXOSMITHKLINE-US2020AMR210164:same reporter US-GLAXOSMITHKLINE-US2020AMR210165:same reporter US-GLAXOSMITHKLINE-US2020AMR210166:same reporter US-GLAXOSMITHKLINE-US2020AMR210156:same reporter